1,102
Views
0
CrossRef citations to date
0
Altmetric
Retraction

Statement of Retraction: Significance of the IL-8 pathway for immunotherapy

This article refers to:
RETRACTED ARTICLE: Significance of the IL-8 pathway for immunotherapy

We, the Publisher of Human Vaccines & Immunotherapeutics, have retracted the following article:

Manuela Gonzalez-Aparicio and Carlos Alfaro, “Significance of the IL-8 pathway for immunotherapy”, Human Vaccines & Immunotherapeutics, volume 16, issue 10, 2312–2317, doi: 10.1080/21645515.2019.1696075

This article has been retracted because it contains an unacceptable level of text overlap with previously published sources:

[1] D. J. J. Waugh and C. Wilson, “The interleukin-8 pathway in cancer,” Clin Cancer Res, vol. 14, pp. 6735-41, Nov 1 2008.

[2] B. S. Qazi, K. Tang, and A. Qazi, “Recent Advances in Underlying Pathologies Provide Insight into Interleukin-8 Expression-Mediated Inflammation and Angiogenesis,” International Journal of Inflammation, vol. 2011, pp. 1-13, 2011.

[3] Q. Liu, A. Li, Y. Tiana, J. D. Wuc, Y. Liud, T. Lib, et al., “The CXCL8-CXCR1/2 pathways in cancer,” Cytokine Growth Factor Review, pp. 61-71, 2016.

[4] N. Vij, A. Sharma, M. Thakkar, S. Sinha, and R. R. Mohan, “PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway,” Molecular Vision, pp. 1020-1027, 2008.

[5] I. M. Bermejo, E. M. Jaffee, D. Davar, J. Cardarelli, D. Williams, P. Phillips, et al., “Phase 1b/2 study of nivolumab in combination with an anti–IL-8 monoclonal antibody, BMS-986253, in a biomarker-enriched population of patients with advanced cancer,” vol. 36, pp. TPS3109-TPS3109, 2018.

The authors did not provide adequate indication of the source material and in their initial response were unable to provide satisfactory details regarding copyright clearance to reproduce the published material.

Author Manuela Gonzalez-Aparicio did not respond, and author Carlos Alfaro Alegría agreed with the decision to retract this article.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Additional information

Funding

No funding

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.